Accessibility Menu
Corvex logo

Corvex(NASDAQ) MOVE

Market Cap$345.45MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-98%
5 Year-98%
1 Year+126%
1 Month-42%
$12.61
+0.88%
+0.11Today
Corvex last closing stock price
MetricPriceDate
Last closeUSD 12.502026-07-24
Corvex stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-10.97%USD 14.042026-07-17
1 month-41.7%USD 21.442026-06-24
3 month-26.99%USD 17.122026-04-24
Year to date+104.27%USD 6.122025-12-31
1 year+126.42%USD 5.522025-07-24
3 year-92.09%USD 157.952023-07-25
5 year-97.51%USD 502.582021-07-23
Since inception-98.29%USD 729.012021-03-23

Corvex Financials at a Glance

Market Cap

$345.45MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$737.00K

Net Income (TTM)

-$18.11M

EPS (TTM)

-$14.43

P/E Ratio

-0.87

Dividend

$0.00

Beta (Volatility)

1.09 (Average)

Price

$12.61

Volume

772

Open

$12.30

Previous Close

$12.61

Daily Range

$12.30 - $13.15

52-Week Range

$3.44 - $26.72

Estimated Earnings Date

Aug 13, 2026

MOVE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Corvex

Movano creates wearable health devices and AI cloud computing services. Its Wellness Ring tracks health metrics for women. The company also offers secure computing for artificial intelligence workloads.

Products and Services

  • Wellness Ring: Wearable device for women, tracks heart rate, sleep, and other health data (100% of FY2025 revenue).
  • Medical Ring: Device with U.S. Food and Drug Administration (FDA) clearance for blood oxygen monitoring, used in clinical settings.
  • AI Cloud Computing: Provides secure, high-performance computing for artificial intelligence, targeting businesses and research organizations (no audited or consolidated FY2025 revenue reported in the company's main financial statements).
  • Token Factory (in development): Platform for premium open-source AI models, aimed at developers and enterprises.
  • Proprietary System-on-a-Chip: Miniaturized chip for future non-invasive blood pressure and glucose monitoring.

Growth and Expansion

  • Completed merger with Corvex OpCo in March 2026, adding AI cloud computing.
  • Launched Wellness Ring in November 2023, targeting women’s health.
  • Received FDA clearance for Medical Ring’s pulse oximetry in November 2024.
  • Formed strategic partnerships with NVIDIA and other technology vendors in 2025.
  • Developed Token Factory platform and expanded data center capacity in 2025-2026.

What Makes Movano Stand Out

Movano combines wearable health technology with secure AI computing services. Its Wellness Ring focuses on women’s health, while its AI division offers advanced security and flexible deployment. The company’s partnerships and proprietary technology support its dual-industry approach.

Five Things You Need to Know

  • FY2025 revenue was $433,000, down 57% from FY2024.
  • Q3 2025 revenue was $80,000, up 60% year-over-year.
  • FY2025 net loss was $18.3 million, improved 23% from FY2024.
  • Cash and cash equivalents were $2.8 million at December 31, 2025.
  • Healthcare segment generated all FY2025 revenue; AI cloud revenue not yet reported.

Bottom Line

Movano has shifted from health wearables to include AI cloud computing. The company’s evolution reflects diversification and adaptation to new technology markets.

AI Generated • Apr 16, 2026

Industry

Technology Hardware, Storage and Peripherals

Employees

38

CEO

Jay Crystal

Headquarters

Pleasanton, VA 22226, US

MOVE Financials

Key Financial Metrics (TTM)

Gross Margin

-302.31%

Operating Margin

-2050.47%

Net Income Margin

-2457.53%

Return on Equity

-12.66%

Return on Capital

-1085.64%

Return on Assets

-3.00%

Earnings Yield

-1.15%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$345.45MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

27.64M

Volume

772

Avg. Volume

56.02K

Financials (TTM)

Gross Profit

-$2.23M

Operating Income

-$15.11M

EBITDA

-$14.49M

Operating Cash Flow

-$11.25M

Capital Expenditure

-$6.24M

Free Cash Flow

-$17.49M

Cash & ST Invst.

$29.33M

Total Debt

$16.81M

Corvex Performance Analysis

Corvex annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 1,013,000N/A
20252025-12-31USD 433,000-57.3%
Corvex sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-50.0%
Q32025-09-30-22.3%
Q42025-12-31-45.0%
Q12026-03-311059.1%
Corvex annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -101.4424.0%
20232023-12-31USD -70.02-31.0%
20242024-12-31USD -29.01-58.6%
20252025-12-31USD -16.02-44.8%
Corvex sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3043.8%
Q32025-09-3087.4%
Q42025-12-31-9126.3%
Q12026-03-3151.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$510.00K

+147.6%

Gross Profit

-$824.00K

+70.6%

Gross Margin

-1.62%

N/A

Market Cap

$345.45MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$9.09M

N/A

Employees

38

N/A

Net Income

-$5.01M

+3.3%

EBITDA

-$4.50M

+12.4%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$29.33M

+573.2%

Total Debt

$16.81M

+8059.2%

Accounts Receivable

$1.50M

N/A

Inventory

$1.78M

-21.3%

Long Term Debt

$6.56M

N/A

Short Term Debt

$10.25M

+4875.2%

Return on Assets

-3.00%

N/A

Return on Invested Capital

-2.58%

N/A

Free Cash Flow

-$10.53M

-144.6%

Operating Cash Flow

-$4.29M

+0.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HSCSHeartSciences Inc.
$2.53+5.86%
NDRAENDRA Life Sciences Inc.
$4.78-1.65%
KTTAPasithea Therapeutics Corp.
$0.45-1.10%
BBLGBone Biologics Corporation
$1.03-4.21%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$91.67-0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.25+0.10%
AALAmerican Airlines Group
$14.95+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.24-0.02%

Questions About MOVE

What is the current price of Corvex?

Corvex is trading at $12.61 per share.

What is the 52-week range for Corvex?

Over the past 52 weeks, Corvex has traded between $3.44 and $26.72.

How much debt does Corvex have?

As of the most recent reporting period, Corvex reported total debt of $18.90M.

How much cash does Corvex have on hand?

Corvex reported $29.33M in cash and cash equivalents in its most recent financial results.

What is Corvex’s dividend yield?

Corvex does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.